Related news from
Tue, 14 May 2024 16:21:00 +0000	Baxter's (BAX) Clinolipid Gets FDA's Expanded Indication Baxter's (BAX) receipt of the latest expanded indication for Clinolipid is expected to meet the diverse nutritional needs of patients, ranging from preterm neonates to adults.
Mon, 13 May 2024 12:45:00 +0000	Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication DEERFIELD, Ill., May 13, 2024--Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, today announced U.S. FDA approval of an expanded indication for Clinolipid (Lipid Injectable Emulsion) to be used in pediatric patients, including preterm and term neonates. Clinolipid is Baxter’s proprietary mixed oil lipid emulsion that is used to provide calories and essential fatty acids in parenteral (intravenous) nutrition (PN) when oral or enteral nutrition is not possible, insuffici
Sat, 11 May 2024 12:34:13 +0000	Baxter International's (NYSE:BAX) Dividend Will Be $0.29 Baxter International Inc. ( NYSE:BAX ) will pay a dividend of $0.29 on the 1st of July. This means the annual payment...
Wed, 08 May 2024 11:14:06 +0000	Baxter International First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags Baxter International ( NYSE:BAX ) First Quarter 2024 Results Key Financial Results Revenue: US$3.59b (up 2.2% from 1Q...
Tue, 07 May 2024 20:15:00 +0000	Baxter to Present at Bank of America 2024 Health Care Conference DEERFIELD, Ill., May 07, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Bank of America 2024 Health Care Conference on Wednesday, May 15, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 3:00 p.m. Pacific Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through Wednesday, August 14, 2024.
Tue, 07 May 2024 13:40:10 +0000	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Tue, 07 May 2024 12:30:00 +0000	Baxter Declares Quarterly Dividend DEERFIELD, Ill., May 07, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on July 1, 2024, to stockholders of record as of May 31, 2024. The indicated annual dividend rate is $1.16 per share of common stock.
Fri, 03 May 2024 16:47:22 +0000	Baxter International Inc. (NYSE:BAX) Q1 2024 Earnings Call Transcript Baxter International Inc. (NYSE:BAX) Q1 2024 Earnings Call Transcript May 2, 2024 Baxter International Inc. beats earnings expectations. Reported EPS is $0.65, expectations were $0.61. Baxter International Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and […]
Fri, 03 May 2024 13:03:26 +0000	The Big Split: 3 Stock Spinoffs Are Coming. Should You Buy? “Do one thing and do it well.” Over time, companies forget that sage advice, preferring instead to build mini empires. Whether through acquisitions or internally developed projects, businesses swell with many tangential businesses. Some end up straying away from the company’s original objective, others are too small to make a difference. The result: a bloated stock where neither the primary business nor the side projects do really well. The answer many companies take is to spin off the ancillary
Fri, 03 May 2024 12:04:58 +0000	Is There An Opportunity With Baxter International Inc.'s (NYSE:BAX) 46% Undervaluation? Key Insights Baxter International's estimated fair value is US$68.31 based on 2 Stage Free Cash Flow to Equity Baxter...
Fri, 03 May 2024 07:09:29 +0000	Baxter International Inc (BAX) Q1 2024 Earnings Call Transcript Highlights: Strong Start with ... Exceeding expectations, Baxter reports significant growth in Pharmaceuticals and Medical Products, despite challenges in Healthcare Systems.
Fri, 03 May 2024 05:08:05 +0000	Decoding Baxter International Inc (BAX): A Strategic SWOT Insight Insightful Analysis of Baxter International Inc's Financial Health and Strategic Position
Thu, 02 May 2024 15:30:03 +0000	Compared to Estimates, Baxter (BAX) Q1 Earnings: A Look at Key Metrics Although the revenue and EPS for Baxter (BAX) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Thu, 02 May 2024 14:03:00 +0000	Baxter (BAX) Q1 Earnings Beat Estimates, '24 EPS View Raised Baxter (BAX) reports better-than-expected first-quarter earnings and sales. BAX's quarterly results reflect solid demand for a range of its medically essential products.
Thu, 02 May 2024 12:33:56 +0000	Baxter International Inc (BAX) Surpasses Q1 Earnings and Revenue Estimates Robust Operational Performance Drives Growth Amidst Strategic Transformations
Thu, 02 May 2024 12:25:09 +0000	Baxter International (BAX) Q1 Earnings and Revenues Surpass Estimates Baxter (BAX) delivered earnings and revenue surprises of 6.56% and 1.20%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Thu, 02 May 2024 11:15:00 +0000	Baxter Reports First-Quarter 2024 Results DEERFIELD, Ill., May 02, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2024.
Mon, 29 Apr 2024 13:16:01 +0000	Ahead of Baxter (BAX) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics Besides Wall Street's top -and-bottom-line estimates for Baxter (BAX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Mon, 29 Apr 2024 12:31:00 +0000	Baxter (BAX) to Report Q1 Earnings: What's in the Cards? Baxter's (BAX) first-quarter results are likely to reflect growth in elective surgical procedures and a more stable supply chain.
Thu, 25 Apr 2024 21:25:06 +0000	ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates ResMed (RMD) delivered earnings and revenue surprises of 10.94% and 1.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?